Efficacy and safety of PDE5 inhibitors in middle-aged and old patients with and without hypogonadism

Chunlin Wanga Chair of Endocrinology and Medical Sexology (ENDOSEX), Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy

https://orcid.org/0000-0002-4742-843X View further author information

Hui Zhanga Chair of Endocrinology and Medical Sexology (ENDOSEX), Department of Systems Medicine, University of Rome Tor Vergata, Rome, ItalyView further author information

Fu Wangb Department of Andrology, Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, ChinaView further author information

Jun Guob Department of Andrology, Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, ChinaView further author information

Jianlin Yuanc Department of Urology, Xijing Hospital, Fourth Military Medical University, Xi’an, ChinaView further author information

Guangdong Houc Department of Urology, Xijing Hospital, Fourth Military Medical University, Xi’an, ChinaView further author information

Ming Gaod Department of Andrology, Xi’an Daxing Hospital affiliated to Yan’an University, Xi’an, ChinaView further author information

Zheng Lie Shanghai Key Laboratory of Reproductive Medicine, Department of Andrology, Center for Men’s Health, Urologic Medical Center, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaView further author information

Yan Zhangf Department of Infertility and Sexual Medicine, 3rd Affiliated Hospital, Sun Yat-sen University, Guangzhou, ChinaCorrespondence[email protected]

https://orcid.org/0000-0003-4119-7359 View further author information

& on behalf of the Marco Polo Study Group on Sexual Health (MAPS-GOSH) show all

Efficacy and safety of PDE5 inhibitors in middle-aged and old patients with and without hypogonadism

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Efficacy and safety of PDE5 inhibitors in middle-aged and old patients with and without hypogonadism

Citations (0)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date